iRay Group (SHA:688301)
China
· Delayed Price · Currency is CNY 114.80
+0.22 (0.19%)
Feb 21, 2025, 3:00 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 16.40 billion as of February 21, 2025. Its market cap has decreased by -40.40% in one year.
Market Cap
16.40B
Enterprise Value
17.73B
Revenue
1.82B
Ranking
n/a
PE Ratio
30.55
Stock Price
114.80
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 16.40B, an increase of 41.23%. That is a compound annual growth rate of 8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 16.40B | 20.12% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | 12.46B | 7.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 310.40B |
| Jiangsu Hengrui Medicine | 295.67B |
| WuXi AppTec | 196.37B |
| Aier Eye Hospital Group | 129.79B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.95B |
| Shanghai United Imaging Healthcare | 116.09B |
| Yunnan Baiyao Group Co.,Ltd | 100.67B |
| Beijing Wantai Biological Pharmacy Enterprise | 87.04B |